Since it targets objects which may pose a risk to human health or involve health insurance resources, the advertising of health products is subject to a specific monitoring regime. However, the heterogeneite of health products explains that the rules put in place differ according to the categories of products and the persons to whom the advertising message is intended. Among those products, medicament is the subject of a restrictive police regime, largely governed by EU law, which is currently confronted with the development of the information and health society 2.0.